Phase I Clinical Trial of Oral COL-3, a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer. If you have the appropriate software installed, you can download article ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results